| 产品编号 | CFN60069 | |
| CAS编号 | 1009119-64-5 | |
| 分子式 = 分子量 | C40H50N8O6 = 738.88 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 1mg | QQ客服:3004468520 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 5mg | QQ客服:3004468520 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 10mg | QQ客服:3004468520 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 20mg | QQ客服:3004468520 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Daclatasvir (BMS-790052, EBP883) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. | |||
| Targets: | HCV NS5A | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3534 mL | 6.767 mL | 13.534 mL | 27.068 mL | 33.835 mL |
| 5 mM | 0.2707 mL | 1.3534 mL | 2.7068 mL | 5.4136 mL | 6.767 mL |
| 10 mM | 0.1353 mL | 0.6767 mL | 1.3534 mL | 2.7068 mL | 3.3835 mL |
| 50 mM | 0.0271 mL | 0.1353 mL | 0.2707 mL | 0.5414 mL | 0.6767 mL |
| 100 mM | 0.0135 mL | 0.0677 mL | 0.1353 mL | 0.2707 mL | 0.3383 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 马尿酸; Hippuric acid | CFN70124 | 495-69-2 | C9H9NO3 = 179.1 | 20mg | QQ客服:3004468091 |
| 原千金藤那布任碱; Prostephanaberrine | CFN97858 | 105608-27-3 | C19H21NO5 = 343.38 | 5mg | QQ客服:3004468091 |
| 芹菜素7-O-(6”-O-丙二酸单酰)-β-D-葡萄糖苷; Apigenin 7-O-(6''-O-malonylglucoside) | CFN95163 | 86546-87-4 | C24H22O13 = 518.4 | 5mg | QQ客服:3004468087 |
| 黄腐酚C; Xanthohumol C | CFN91509 | 189299-05-6 | C21H20O5 = 352.4 | 5mg | QQ客服:3004468091 |